What Researchers Did
Researchers reviewed 14 published studies to see how oxygen therapy affects people with obstructive sleep apnea, a condition where breathing repeatedly stops during sleep.
What They Found
This systematic review and meta-analysis of 14 studies involving 359 patients found that oxygen therapy improved blood oxygen levels compared to placebo in ten of the studies. Nine studies used a single-group design, while five were randomized trials comparing CPAP, oxygen, and placebo or sham CPAP. When CPAP was compared with oxygen therapy, all but one study showed CPAP produced a bigger improvement in the apnea-hypopnea index, a measure of how often breathing problems occur during sleep. However, patients on oxygen therapy had longer average episodes of apnea and hypopnea than those on placebo.
What This Means for Canadian Patients
This abstract does not mention hyperbaric oxygen therapy (HBOT), so it does not address HBOT or its use. The findings apply to standard supplemental oxygen therapy, not hyperbaric treatment. The abstract itself notes that while oxygen therapy raised blood oxygen levels, it also lengthened the duration of apnea and hypopnea episodes, and CPAP outperformed oxygen therapy on the apnea-hypopnea index in nearly all the studies reviewed.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
Most of the reviewed studies were small single-group designs rather than randomized trials, and the review found that oxygen therapy, despite improving blood oxygen saturation, may worsen the duration of individual apnea and hypopnea events.